These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Chamilos G; Kontoyiannis DP Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654 [TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus. Tetsuka N; Yaguchi T; Machida H; Ito S; Miyairi I Pediatr Int; 2017 Mar; 59(3):362-363. PubMed ID: 28317305 [No Abstract] [Full Text] [Related]
4. Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study. Imbert S; Cassaing S; Bonnal C; Normand AC; Gabriel F; Costa D; Blaize M; Lachaud L; Hasseine L; Kristensen L; Guitard J; Schuttler C; Raberin H; Brun S; Hendrickx M; Piarroux R; Fekkar A Mycoses; 2021 Nov; 64(11):1346-1353. PubMed ID: 34181773 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study. Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature. Mayr A; Lass-Flörl C Eur J Med Res; 2011 Apr; 16(4):153-7. PubMed ID: 21486729 [TBL] [Abstract][Full Text] [Related]
7. Diagnostics and susceptibility testing in Aspergillus. Bernal-Martínez L; Alastruey-Izquierdo A; Cuenca-Estrella M Future Microbiol; 2016; 11(2):315-28. PubMed ID: 26848512 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Antifungal Susceptibility Profile of Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982 [TBL] [Abstract][Full Text] [Related]
10. Molecular typing and antifungal susceptibility study of Aspergillus spp. in intensive care unit (ICU) patients in Indonesia. Rozaliyani A; Sedono R; Sjam R; Tugiran M; Adawiyah R; Setianingrum F; Jusuf A; Sungkar S; Hagen F; Meis JF; Wahyuningsih R J Infect Dev Ctries; 2021 Jul; 15(7):1014-1020. PubMed ID: 34343127 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates. Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488 [TBL] [Abstract][Full Text] [Related]
12. Aspergillus species intrinsically resistant to antifungal agents. Van Der Linden JW; Warris A; Verweij PE Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634 [TBL] [Abstract][Full Text] [Related]
13. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens. Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826 [TBL] [Abstract][Full Text] [Related]
15. Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples. White PL; Posso RB; Barnes RA J Clin Microbiol; 2017 Aug; 55(8):2356-2366. PubMed ID: 28515217 [TBL] [Abstract][Full Text] [Related]
16. Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor. Harada S; Ohkushi D; Nakano K; Mitani H; Yamamoto Y; Kamei K; Hayama B J Infect Chemother; 2020 Mar; 26(3):301-304. PubMed ID: 31787529 [TBL] [Abstract][Full Text] [Related]
17. Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies. van de Peppel RJ; van der Beek MT; Visser LG; de Boer MGJ; Wallinga J Int J Antimicrob Agents; 2019 Mar; 53(3):284-293. PubMed ID: 30395989 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility testing in Aspergillus species: an update. Lass-Flörl C Future Microbiol; 2010 May; 5(5):789-99. PubMed ID: 20441550 [TBL] [Abstract][Full Text] [Related]
19. Aspergillus--classification and antifungal susceptibilities. Buzina W Curr Pharm Des; 2013; 19(20):3615-28. PubMed ID: 23278534 [TBL] [Abstract][Full Text] [Related]
20. Animal models of invasive aspergillosis for drug discovery. Paulussen C; Boulet GA; Cos P; Delputte P; Maes LJ Drug Discov Today; 2014 Sep; 19(9):1380-6. PubMed ID: 24931219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]